QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=9B4D5A7C7AB117ED9E3E04C1F89E04C2;jsessionid=CBA295A848D2E2C432F1D22991BA68F2;jsessionid=1B27B4AB3F06DD748BEDA42B7E6E52B3;jsessionid=5AD86222968F17ECDC46B86AAADAA8EF (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=9B4D5A7C7AB117ED9E3E04C1F89E04C2;jsessionid=CBA295A848D2E2C432F1D22991BA68F2;jsessionid=1B27B4AB3F06DD748BEDA42B7E6E52B3;jsessionid=5AD86222968F17ECDC46B86AAADAA8EF